Duquesne University   Report issue

Academic/Hospital Phase 1 Phase 2
Founded: Pittsburgh PA United States (1878)

Organization Overview

First Clinical Trial
2008
NCT01152580
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Duquesne University | Duquesne University School of Pharmacy | Paula Witt-Enderby

Active Ingredients

Drugs in Phase 2 Trials (1)

melatonin (4 trials)

Drugs in Phase 1 Trials (3)

menaquinone (1 trial)

strontium-89 (1 trial)

vitamin d3 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Bone Diseases, Metabolic (Phase 1)

Osteoporosis (Phase 1)

Substance Withdrawal Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 4